Valeant Pharmaceuticals Intl (TSE: VRX) has recently received a number of price target changes and ratings updates:

11/28/2016 – Valeant Pharmaceuticals Intl had its “sector perform” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a C$39.00 price target on the stock.

11/18/2016 – Valeant Pharmaceuticals Intl had its “sector perform” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a C$39.00 price target on the stock.

11/10/2016 – Valeant Pharmaceuticals Intl had its price target lowered by analysts at TD Securities from C$38.50 to C$18.00. They now have a “hold” rating on the stock.

11/9/2016 – Valeant Pharmaceuticals Intl had its price target lowered by analysts at Scotiabank from C$32.00 to C$17.00. They now have a “sector perform” rating on the stock.

11/9/2016 – Valeant Pharmaceuticals Intl had its price target lowered by analysts at Royal Bank Of Canada from C$47.00 to C$39.00. They now have a “sector perform” rating on the stock.

11/1/2016 – Valeant Pharmaceuticals Intl had its price target lowered by analysts at Scotiabank from C$34.00 to C$32.00. They now have a “sector perform” rating on the stock.

10/31/2016 – Valeant Pharmaceuticals Intl had its “sector perform” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a C$47.00 price target on the stock.

10/25/2016 – Valeant Pharmaceuticals Intl had its “sector perform” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a C$46.50 price target on the stock.

10/11/2016 – Valeant Pharmaceuticals Intl had its “sector perform” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a C$35.00 price target on the stock, down previously from C$36.00.

10/3/2016 – Valeant Pharmaceuticals Intl had its “outperform” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a C$46.00 price target on the stock.

Valeant Pharmaceuticals Intl Inc (TSE:VRX) traded down 7.85% on Wednesday, reaching $21.24. 2,778,991 shares of the company’s stock were exchanged. Valeant Pharmaceuticals Intl Inc has a one year low of $18.41 and a one year high of $165.77. The firm has a 50 day moving average of $26.29 and a 200-day moving average of $31.45. The stock’s market cap is $7.38 billion.